About
Our Digwal, India facility is a USFDA, UK MHRA, PMDA JAPAN and ANVISA inspected site that offers development and commercial GMP manufacturing of Active Pharmaceutical Ingredients (APIs) / key intermediates. Site is equipped with R&D lab, pilot plant, commercial blocks, quality control lab, utility system and centralized Zero Liquid Discharge plant.